Lef1 haploinsufficient mice display a low turnover an low bone mass phenotype in a gender- and age- specific manner

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Noh, Tommy ^a   Gabet, Yankel ^a   Cogan, Jon ^a   Shi, Yunfan ^a   Tank, Archana ^a   Sasaki, Tomoyo ^b   Criswell, Braden ^a   Dixon, Alexis ^a   Lee, Christopher ^a   Tam, Joseph ^c   Kohler, Thomas ^d   Segev, Eran ^c   Kockeritz, Lisa ^e   Woodgett, James ^e   Müller, Ralph ^d   Chai, Yang ^b   Smith, Elisheva ^a   Bab, Itai ^c   Frenkel, Baruch ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d ETH ZURICH   (Switzerland)

^e PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; LYMPHOID ENHANCER FACTOR 1; WNT PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; LEF1 PROTEIN, MOUSE; MESSENGER RNA; PRIMER DNA;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE METABOLISM; BONE REMODELING; BONE TURNOVER; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; PHENOTYPE; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TRABECULAR BONE; ANIMAL; BONE; BONE DENSITY; C57BL MOUSE; COMPUTER ASSISTED TOMOGRAPHY; GENETICS; HETEROZYGOTE; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; RADIOGRAPHY;

MUS;

AGE FACTORS; ANIMALS; BASE SEQUENCE; BONE AND BONES; BONE DENSITY; BONE REMODELING; DNA PRIMERS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HETEROZYGOTE; LYMPHOID ENHANCER-BINDING FACTOR 1; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; PHENOTYPE; RECEPTORS, ANDROGEN; RNA, MESSENGER; SEX FACTORS; SIGNAL TRANSDUCTION; TOMOGRAPHY, X-RAY COMPUTED; WNT PROTEINS;

EID: 65549154420     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005438     Document Type: Article

References (71)

1. Miller JR, Moon RT (1996) Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes Dev 10: 2527-2539.
2. Cadigan KM, Nusse R (1997) Wnt signaling: a common theme in animal development. Genes Dev 11: 3286-3305.
3. Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, et al. (1996) A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382: 225-230.
4. He X, Saint-Jeannet JP, Wang Y, Nathans J, Dawid I, et al. (1997) A member of the Frizzledprotein family mediating axis induction by Wnt-5A. Science 275: 1652-1654.
5. Yang-Snyder J, Miller JR, Brown JD, Lai CJ, Moon RT (1996) A frizzled homolog functions in a vertebrate Wnt signaling pathway. Curr Biol 6: 1302-1306.
6. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC (2000) An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407: 535-538.
7. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, et al. (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407: 530-535.
8. Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, et al. (2000) arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407: 527-530.
9. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P (1998) Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 8: 573-581.
10. Itoh K, Krupnik VE, Sokol SY (1998) Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin. Curr Biol 8: 591-594.
11. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, et al. (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. Embo J 17: 1371-1384.
12. Travis A, Amsterdam A, Belanger C, Grosschedl R (1991) LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]. Genes Dev 5: 880-894.
13. Waterman ML, Fischer WH, Jones KA (1991) A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer. Genes Dev 5: 656-669.
14. van de Wetering M, Oosterwegel M, Dooijes D, Clevers H (1991) Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. Embo J 10: 123-132.
15. Korinek V, Barker N, Willert K, Molenaar M, Roose J, et al. (1998) Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse. Mol Cell Biol 18: 1248-1256.
16. Bab I, Müller R, Hajbi-Yonissi C, Gabet Y (2007) Micro-Tomographic Atlas of the Mouse Skeleton. New York: Springer.
17. Neu CM, Manz F, Rauch F, Merkel A, Schoenau E (2001) Bone densities and bone size at the distal radius in healthy children and adolescents: a study using peripheral quantitative computed tomography. Bone 28: 227-232.
18. Macdonald H, Kontulainen S, Petit M, Janssen P, McKay H (2006) Bone strength and its determinants in pre- and early pubertal boys and girls. Bone 39: 598-608.
19. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML (2007) Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res 22: 1197-1207.
20. Juttner KV, Perry MJ (2007) High-dose estrogen-induced osteogenesis is decreased in aged RUNX2(+/-) mice. Bone 41: 25-32.
21. Pantschenko AG, Zhang W, Nahounou M, McCarthy MB, Stover ML, et al. (2005) Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice. J Bone Miner Res 20: 1414-1429.
22. Glass DA 2nd, Karsenty G (2006) Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway. Curr Top Dev Biol 73: 43-84.
23. Glass DA 2nd, Bialek P, Ahn JD, Starbuck M, Patel MS, et al. (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8: 751-764.
24. Holmen SL, Giambernardi TA, Zylstra CR, Buckner-Berghuis BD, Resau JH, et al. (2004) Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res 19: 2033-2040.
25. Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, et al. (2005) Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 102: 3324-3329.
26. Kugimiya F, Kawaguchi H, Ohba S, Kawamura N, Hirata M, et al. (2007) GSK-3beta controls osteogenesis through regulating Runx2 activity. PLoS ONE 2: e837. doi:10.1371/journal.pone.0000837.
27. Morvan F, Boulukos K, Clement-Lacroix P, Roman Roman S, Suc-Royer I, et al. (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21: 934-945.
28. Li X, Liu P, Liu W, Maye P, Zhang J, et al. (2005) Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet 37: 945-952.
29. Bodine PV, Zhao W, Kharode YP, Bex FJ, Lambert AJ, et al. (2004) The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 18: 1222-1237.
30. Kamiya N, Ye L, Kobayashi T, Mochida Y, Yamauchi M, et al. (2008) BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 135: 3801-3811.
31. Smith E, Coetzee GA, Frenkel B (2002) Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta. J Biol Chem 277: 18191-18197.
32. Ohnaka K, Taniguchi H, Kawate H, Nawata H, Takayanagi R (2004) Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun 318: 259-264.
33. Leclerc N, Noh T, Cogan J, Samarawickrama DB, Smith E, et al. (2007) Opposing effects of glucocorticoids and Wnt signaling on Krox20 and mineral deposition in osteoblast cultures. J Cell Biochem.
34. Wang FS, Lin CL, Chen YJ, Wang CJ, Yang KD, et al. (2005) Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology 146: 2415-2423.
35. Armstrong VJ, Muzylak M, Sunters A, Zaman G, Saxon LK, et al. (2007) Wnt/ beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha. J Biol Chem 282: 20715-20727.
36. van Genderen C, Okamura RM, Farinas I, Quo RG, Parslow TG, et al. (1994) Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 8: 2691-2703.
37. Galceran J, Farinas I, Depew MJ, Clevers H, Grosschedl R (1999) Wnt3a-/- like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. Genes Dev 13: 709-717.
38. Okamura RM, Sigvardsson M, Galceran J, Verbeek S, Clevers H, et al. (1998) Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1. Immunity 8: 11-20.
39. Staal FJ, Meeldijk J, Moerer P, Jay P, van de Weerdt BC, et al. (2001) Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. Eur J Immunol 31: 285-293.
40. Galceran J, Miyashita-Lin EM, Devaney E, Rubenstein JL, Grosschedl R (2000) Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. Development 127: 469-482.
41. Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, et al. (2003) High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18: 960-974.
42. Akhter MP, Wells DJ, Short SJ, Cullen DM, Johnson ML, et al. (2004) Bone biomechanical properties in LRP5 mutant mice. Bone 35: 162-169.
43. Sawakami K, Robling AG, Ai M, Pitner ND, Liu D, et al. (2006) The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J Biol Chem 281: 23698-23711.
44. Wu Y, Torchia J, Yao W, Lane NE, Lanier LL, et al. (2007) Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency. PLoS ONE 2: e586. doi:10.1371/journal.pone.0000586.
45. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C (2005) Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8: 727-738.
46. DeMambro VE, Clemmons DR, Horton LG, Bouxsein ML, Wood TL, et al. (2008) Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. Endocrinology 149: 2051-2061.
47. Pennypacker B, Shea M, Liu Q, Masarachia P, Saftig P, et al. (2008) Bone density, strength, and formation in adult cathepsin K (-/-) mice. Bone.
48. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, et al. (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406: 86-90.
49. Liu XH, Kirschenbaum A, Yao S, Liu G, Aaronson SA, et al. (2007) Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells. Cancer Res 67: 5747-5753.
50. Liu XH, Kirschenbaum A, Yao S, Levine AC (2007) Androgens Promote Preosteoblast Differentiation via Activation of the Canonical Wnt Signaling Pathway. Ann N Y Acad Sci 1116: 423-431.
51. Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, et al. (2006) Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147: 141-154.
52. Lyon MF, Hawkes SG (1970) X-linked gene for testicular feminization in the mouse. Nature 227: 1217-1219.
53. Lyon MF (1961) Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190: 372-373.
54. Vandenput L, Swinnen JV, Boonen S, Van Herck E, Erben RG, et al. (2004) Role of the androgen receptor in skeletal homeostasis: the androgen-resistant testicular feminized male mouse model. J Bone Miner Res 19: 1462-1470.
55. Matsumoto C, Inada M, Toda K, Miyaura C (2006) Estrogen and androgen play distinct roles in bone turnover in male mice before and after reaching sexual maturity. Bone 38: 220-226.
56. Dubrow SA, Hruby PM, Akhter MP (2007) Gender specific LRP5 influences on trabecular bone structure and strength. J Musculoskelet Neuronal Interact 7: 166-173.
57. Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, et al. (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135: 825-837.
58. Migliaccio A, Varricchio L, De Falco A, Castoria G, Arra C, et al. (2007) Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth. Oncogene 26: 6619-6629.
59. Kang HY, Cho CL, Huang KL, Wang JC, Hu YC, et al. (2004) Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts. J Bone Miner Res 19: 1181-1190.
60. Smith E, Frenkel B (2005) Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner. J Biol Chem 280: 2388-2394.
61. Nantermet PV, Xu J, Yu Y, Hodor P, Holder D, et al. (2004) Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland. J Biol Chem 279: 1310-1322.
62. Kahler RA, Galindo M, Lian J, Stein GS, van Wijnen AJ, et al. (2006) Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts. J Cell Biochem 97: 969-983.
63. Kahler RA, Westendorf JJ (2003) Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. J Biol Chem 278: 11937-11944.
64. Mishina Y, Starbuck MW, Gentile MA, Fukuda T, Kasparcova V, et al. (2004) Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J Biol Chem 279: 27560-27566.
65. Bajayo A, Goshen I, Feldman S, Csernus V, Iverfeldt K, et al. (2005) Central IL-1 receptor signaling regulates bone growth and mass. Proc Natl Acad Sci U S A 102: 12956-12961.
66. Yirmiya R, Goshen I, Bajayo A, Kreisel T, Feldman S, et al. (2006) Depression induces bone loss through stimulation of the sympathetic nervous system. Proc Natl Acad Sci U S A 103: 16876-16881.
67. Ruegsegger P, Koller B, Muller R (1996) A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int 58: 24-29.
68. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P (1999) Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14: 1167-1174.
69. Erlebacher A, Derynck R (1996) Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132: 195-210.
70. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, et al. (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610.
71. Leclerc N, Noh T, Cogan J, Samarawickrama DB, Smith E, et al. (2008) Opposing effects of glucocorticoids and Wnt signaling on Krox20 and mineral deposition in osteoblast cultures. J Cell Biochem 103: 1938-1951.